{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:06:02Z","timestamp":1791353162378,"version":"4.3.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/leu.2016.143","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T09:46:36Z","timestamp":1464083196000},"page":"1861-1868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia"],"prefix":"10.1038","volume":"30","author":[{"given":"G","family":"Heller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Topakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Altenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Cerny-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Herndlhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Datlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Byrgazov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mannhalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"H\u00f6rmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W R","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C C","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Z\u00f6chbauer-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"BFleu2016143_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ . Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7: 441\u2013453.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2016143_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/138920212802510466","volume":"13","author":"KM Greulich-Bode","year":"2012","unstructured":"Greulich-Bode KM, Heinze B . On the power of additional and complex chromosomal aberrations in CML. Curr Genomics 2012; 13: 471\u2013476.","journal-title":"Curr Genomics"},{"key":"BFleu2016143_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T . Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010; 120: 2254\u20132264.","journal-title":"J Clin Invest"},{"key":"BFleu2016143_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1634\/theoncologist.5-5-405","volume":"5","author":"A Di Bacco","year":"2000","unstructured":"Di Bacco A, Keeshan K, McKenna SL, Cotter TG . Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. Oncologist 2000; 5: 405\u2013415.","journal-title":"Oncologist"},{"key":"BFleu2016143_CR5","doi-asserted-by":"publisher","first-page":"e22110","DOI":"10.1371\/journal.pone.0022110","volume":"6","author":"J Jelinek","year":"2011","unstructured":"Jelinek J, Gharibyan V, Estecio MR, Kondo K, He R, Chung W et al. Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One 2011; 6: e22110.","journal-title":"PLoS One"},{"key":"BFleu2016143_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1476-4598-9-44","volume":"9","author":"T Dunwell","year":"2010","unstructured":"Dunwell T, Hesson L, Rauch TA, Wang L, Clark RE, Dallol A et al. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer 2010; 9: 44.","journal-title":"Mol Cancer"},{"key":"BFleu2016143_CR7","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1038\/ncomms8091","volume":"6","author":"G Amabile","year":"2015","unstructured":"Amabile G, Di Ruscio A, Muller F, Welner RS, Yang H, Ebralidze AK et al. Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun 2015; 6: 7091.","journal-title":"Nat Commun"},{"key":"BFleu2016143_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nsmb.1594","volume":"16","author":"R Straussman","year":"2009","unstructured":"Straussman R, Nejman D, Roberts D, Steinfeld I, Blum B, Benvenisty N et al. Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol 2009; 16: 564\u2013571.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu2016143_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature05918","volume":"447","author":"W Reik","year":"2007","unstructured":"Reik W . Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447: 425\u2013432.","journal-title":"Nature"},{"key":"BFleu2016143_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA, Li E . DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99: 247\u2013257.","journal-title":"Cell"},{"key":"BFleu2016143_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ceb.2007.04.011","volume":"19","author":"M Weber","year":"2007","unstructured":"Weber M, Schubeler D . Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr Opin Cell Biol 2007; 19: 273\u2013280.","journal-title":"Curr Opin Cell Biol"},{"key":"BFleu2016143_CR12","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1073\/pnas.052410099","volume":"99","author":"D Takai","year":"2002","unstructured":"Takai D, Jones PA . Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002; 99: 3740\u20133745.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016143_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484\u2013492.","journal-title":"Nat Rev Genet"},{"key":"BFleu2016143_CR14","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A . CpG islands and the regulation of transcription. Genes Dev 2011; 25: 1010\u20131022.","journal-title":"Genes Dev"},{"key":"BFleu2016143_CR15","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1182\/blood-2011-09-382770","volume":"119","author":"V Ghanim","year":"2012","unstructured":"Ghanim V, Herrmann H, Heller G, Peter B, Hadzijusufovic E, Blatt K et al. 5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand. Blood 2012; 119: 4242\u20134252.","journal-title":"Blood"},{"key":"BFleu2016143_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/carcin\/bgs363","volume":"34","author":"G Heller","year":"2013","unstructured":"Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C et al. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis 2013; 34: 513\u2013521.","journal-title":"Carcinogenesis"},{"key":"BFleu2016143_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M . Epigenetics in cancer. N Engl J Med 2008; 358: 1148\u20131159.","journal-title":"N Engl J Med"},{"key":"BFleu2016143_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1126\/science.1697983","volume":"249","author":"WM Rideout 3rd","year":"1990","unstructured":"Rideout WM 3rd, Coetzee GA, Olumi AF, Jones PA . 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990; 249: 1288\u20131290.","journal-title":"Science"},{"key":"BFleu2016143_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1172\/JCI69739","volume":"124","author":"SC Navada","year":"2014","unstructured":"Navada SC, Steinmann J, Lubbert M, Silverman LR . Clinical development of demethylating agents in hematology. J Clin Invest 2014; 124: 40\u201346.","journal-title":"J Clin Invest"},{"key":"BFleu2016143_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/5047","volume":"21","author":"EE Cameron","year":"1999","unstructured":"Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB . Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999; 21: 103\u2013107.","journal-title":"Nat Genet"},{"key":"BFleu2016143_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/sj.onc.1209115","volume":"25","author":"G Heller","year":"2006","unstructured":"Heller G, Fong KM, Girard L, Seidl S, End-Pf\u00fctzenreuter A, Lang G et al. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene 2006; 25: 959\u2013968.","journal-title":"Oncogene"},{"key":"BFleu2016143_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.18632\/oncotarget.2697","volume":"6","author":"G Heller","year":"2015","unstructured":"Heller G, Altenberger C, Schmid B, Marhold M, Tomasich E, Ziegler B et al. DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers. Oncotarget 2015; 6: 394\u2013408.","journal-title":"Oncotarget"},{"key":"BFleu2016143_CR23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1158\/1078-0432.CCR-11-2450","volume":"18","author":"G Heller","year":"2012","unstructured":"Heller G, Weinzierl M, Noll C, Babinsky V, Ziegler B, Altenberger C et al. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clin Cancer Res 2012; 18: 1619\u20131629.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016143_CR24","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger F, Andrews SR . Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 2011; 27: 1571\u20131572.","journal-title":"Bioinformatics"},{"key":"BFleu2016143_CR25","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1101\/gr.092759.109","volume":"19","author":"M Krzywinski","year":"2009","unstructured":"Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D et al. Circos: an information aesthetic for comparative genomics. Genome Res 2009; 19: 1639\u20131645.","journal-title":"Genome Res"},{"key":"BFleu2016143_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28: 495\u2013501.","journal-title":"Nat Biotechnol"},{"key":"BFleu2016143_CR27","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/gb-2010-11-8-r86","volume":"11","author":"J Goecks","year":"2010","unstructured":"Goecks J, Nekrutenko A, Taylor J . Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010; 11: R86.","journal-title":"Genome Biol"},{"key":"BFleu2016143_CR28","unstructured":"Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M et al. Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol Chapter 19 (Unit): 191\u201321."},{"key":"BFleu2016143_CR29","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gr.4086505","volume":"15","author":"B Giardine","year":"2005","unstructured":"Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res 2005; 15: 1451\u20131455.","journal-title":"Genome Res"},{"key":"BFleu2016143_CR30","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL . TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.","journal-title":"Genome Biol"},{"key":"BFleu2016143_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G et al. Integrative genomics viewer. Nat Biotechnol 2011; 29: 24\u201326.","journal-title":"Nat Biotechnol"},{"key":"BFleu2016143_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/1078-0432.CCR-13-2053","volume":"20","author":"A Erdreich-Epstein","year":"2014","unstructured":"Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clin Cancer Res 2014; 20: 827\u2013836.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016143_CR33","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1182\/blood-2011-06-358705","volume":"119","author":"S Agrawal-Singh","year":"2012","unstructured":"Agrawal-Singh S, Isken F, Agelopoulos K, Klein HU, Thoennissen NH, Koehler G et al. Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood 2012; 119: 2346\u20132357.","journal-title":"Blood"},{"key":"BFleu2016143_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/hmg\/4.4.667","volume":"4","author":"T Kohno","year":"1995","unstructured":"Kohno T, Otsuka T, Takano H, Yamamoto T, Hamaguchi M, Terada M et al. Identification of a novel phospholipase C family gene at chromosome 2q33 that is homozygously deleted in human small cell lung carcinoma. Hum Mol Genet 1995; 4: 667\u2013674.","journal-title":"Hum Mol Genet"},{"key":"BFleu2016143_CR35","doi-asserted-by":"publisher","first-page":"e66114","DOI":"10.1371\/journal.pone.0066114","volume":"8","author":"Z Shan","year":"2013","unstructured":"Shan Z, Shakoori A, Bodaghi S, Goldsmith P, Jin J, Wiest JS . TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLoS One 2013; 8: e66114.","journal-title":"PLoS One"},{"key":"BFleu2016143_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10555-010-9203-x","volume":"29","author":"G Heller","year":"2010","unstructured":"Heller G, Zielinski CC, Z\u00f6chbauer-M\u00fcller S . Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 2010; 29: 95\u2013107.","journal-title":"Cancer Metastasis Rev"},{"key":"BFleu2016143_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3892\/ol.2011.419","volume":"3","author":"E Uehara","year":"2012","unstructured":"Uehara E, Takeuchi S, Yang Y, Fukumoto T, Matsuhashi Y, Tamura T et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. Oncol Lett 2012; 3: 190\u2013192.","journal-title":"Oncol Lett"},{"key":"BFleu2016143_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3324\/haematol.2009.015693","volume":"95","author":"JJ Janssen","year":"2010","unstructured":"Janssen JJ, Denkers F, Valk P, Cornelissen JJ, Schuurhuis GJ, Ossenkoppele GJ . Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells. Haematologica 2010; 95: 1036\u20131037.","journal-title":"Haematologica"},{"key":"BFleu2016143_CR39","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nmeth.2632","volume":"10","author":"KB Michels","year":"2013","unstructured":"Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I et al. Recommendations for the design and analysis of epigenome-wide association studies. Nat Methods 2013; 10: 949\u2013955.","journal-title":"Nat Methods"},{"key":"BFleu2016143_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nmeth.1414","volume":"7","author":"H Gu","year":"2010","unstructured":"Gu H, Bock C, Mikkelsen TS, Jager N, Smith ZD, Tomazou E et al. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 2010; 7: 133\u2013136.","journal-title":"Nat Methods"},{"key":"BFleu2016143_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrg3273","volume":"13","author":"C Bock","year":"2012","unstructured":"Bock C . Analysing and interpreting DNA methylation data. Nat Rev Genet 2012; 13: 705\u2013719.","journal-title":"Nat Rev Genet"},{"key":"BFleu2016143_CR42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2174\/15680096113139990085","volume":"13","author":"M Cea","year":"2013","unstructured":"Cea M, Cagnetta A, Nencioni A, Gobbi M, Patrone F . New insights into biology of chronic myeloid leukemia: implications in therapy. Curr Cancer Drug Targets 2013; 13: 711\u2013723.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFleu2016143_CR43","doi-asserted-by":"publisher","first-page":"12117","DOI":"10.1073\/pnas.0409097102","volume":"102","author":"G Perini","year":"2005","unstructured":"Perini G, Diolaiti D, Porro A, Della Valle G . In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci USA 2005; 102: 12117\u201312122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016143_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/hmg\/ddg028","volume":"12","author":"J Kim","year":"2003","unstructured":"Kim J, Kollhoff A, Bergmann A, Stubbs L . Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. Hum Mol Genet 2003; 12: 233\u2013245.","journal-title":"Hum Mol Genet"},{"key":"BFleu2016143_CR45","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1101\/gr.136101.111","volume":"22","author":"H Wang","year":"2012","unstructured":"Wang H, Maurano MT, Qu H, Varley KE, Gertz J, Pauli F et al. Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Res 2012; 22: 1680\u20131688.","journal-title":"Genome Res"},{"key":"BFleu2016143_CR46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vire","year":"2006","unstructured":"Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439: 871\u2013874.","journal-title":"Nature"},{"key":"BFleu2016143_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1158\/0008-5472.CAN-07-2531","volume":"68","author":"G Heller","year":"2008","unstructured":"Heller G, Schmidt WM, Ziegler B, Holzer S, M\u00fcllauer L, Bilban M et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer Res 2008; 68: 44\u201354.","journal-title":"Cancer Res"},{"key":"BFleu2016143_CR48","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1158\/1078-0432.CCR-13-3380","volume":"20","author":"ZJ Liu","year":"2014","unstructured":"Liu ZJ, Zhang J, Gao YH, Pei LR, Zhou J, Gu LK et al. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis. Clin Cancer Res 2014; 20: 4598\u20134612.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016143_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-006-9377-7","volume":"103","author":"G Heller","year":"2007","unstructured":"Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM et al. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat 2007; 103: 283\u2013291.","journal-title":"Breast Cancer Res Treat"},{"key":"BFleu2016143_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0609.2005.00559.x","volume":"76","author":"A Aggerholm","year":"2006","unstructured":"Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P . Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol 2006; 76: 23\u201332.","journal-title":"Eur J Haematol"},{"key":"BFleu2016143_CR51","doi-asserted-by":"publisher","first-page":"28324","DOI":"10.1074\/jbc.271.45.28324","volume":"271","author":"YM Tang","year":"1996","unstructured":"Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR et al. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 1996; 271: 28324\u201328330.","journal-title":"J Biol Chem"},{"key":"BFleu2016143_CR52","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/ajh.23511","volume":"88","author":"CD DiNardo","year":"2013","unstructured":"DiNardo CD, Gharibyan V, Yang H, Wei Y, Pierce S, Kantarjian HM et al. Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia. Am J Hematol 2013; 88: 784\u2013789.","journal-title":"Am J Hematol"},{"key":"BFleu2016143_CR53","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1007\/s00018-014-1707-z","volume":"71","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhang J, Ye M, Zhu M, Zhang B, Roy M et al. Tumor suppressor role of protein 4.1B\/DAL-1. Cell Mol Life Sci 2014; 71: 4815\u20134830.","journal-title":"Cell Mol Life Sci"},{"key":"BFleu2016143_CR54","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1200\/JCO.2005.11.981","volume":"23","author":"JP Issa","year":"2005","unstructured":"Issa JP, Gharibyan V, Cortes J, Jelinek J, Morris G, Verstovsek S et al. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol 2005; 23: 3948\u20133956.","journal-title":"J Clin Oncol"},{"key":"BFleu2016143_CR55","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cncr.22470","volume":"109","author":"Y Oki","year":"2007","unstructured":"Oki Y, Kantarjian HM, Gharibyan V, Jones D, O'Brien S, Verstovsek S et al. Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia. Cancer 2007; 109: 899\u2013906.","journal-title":"Cancer"},{"key":"BFleu2016143_CR56","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/leu.2014.272","volume":"28","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Rinke J, Schafer V, Schnittger S, Kohlmann A, Obstfelder E et al. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia 2014; 28: 2292\u20132299.","journal-title":"Leukemia"},{"issue":"Suppl","key":"BFleu2016143_CR57","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.clml.2015.02.035","volume":"15","author":"S Soverini","year":"2015","unstructured":"Soverini S, de Benedittis C, Mancini M, Martinelli G . Mutations in the BCR-ABL1 kinase domain and elsewhere in chronic myeloid leukemia. Clin Lymphoma Myeloma Leuk 2015; 15 (Suppl): S120\u2013S128.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFleu2016143_CR58","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","volume":"117","author":"H Makishima","year":"2011","unstructured":"Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H et al. CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood 2011; 117: e198\u2013e206.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2016143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:05:34Z","timestamp":1684433134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFleu2016143"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.143","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]},"assertion":[{"value":"23 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PV received research grants from Novartis and Ariad. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}